I studied the effects of serum dilution and oxidation of albumin-bound bilirubin on the accuracy of results by the peroxidase method for assessing bilirubin-albumin binding. The apparent concentration of unbound bilirubin decreases with dilution of bilirubin-enriched serum or defatted-albumin solutions, the effect being more marked with serum. The decrease in apparent unbound bilirubin does not appear to be due to slow oxidation of albumin-bound bilirubin. Instead, the bilirubin-albumin complex has a much lower apparent dissociation rate constant (K. causing the dissociation of the complex to be rate-limiting when serum is analyzed at the currently recommended 40-fold dilution and peroxidase concentration (0.11 imol/L). In addition, dilution appears to enhance bilirubin binding by serum but not by defatted-albumin solutions. Decreasing the serum dilution and peroxidase concentration may significantly improve the accuracy of the peroxidase test. The actual correlation between clinical bilirubin toxicity and specific unbound bilirubin concentrations, however, remains to be determined.
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The peroxidase method for determining the apparent unbound bilirubin concentration (AUBC)' in sera from jaundiced infants is a sensitive, precise, and now automated test currently in use in several clinical laboratories (1) In an effort to clarify the effects of serum dilution and oxidation of albumin-bound biirubin on the peroxidase analysis of bilirubin-albumin binding, I undertook the following studies. 
Materials and Methods

Reagents and Solutions
where K is the rate constant (Table 1 ) and (HRP) is the concentration of horseradish peroxidase.
For total bilirubin concentrations >30 tmol/L, I used cuvets of 0.2-or 1.0-cm pathlength. Serum was diluted with phosphate buffer, or in some cases with serum ultrafiltrate obtained by filtering serum through CF 25 membrane cones (Ainicon Corp., Lexington, MA 02173). In some experiments, I used potassium ferricyanide instead of HRP-EtOOH as the bilirubin oxidizing agent (11) . The mean rate constant for the ferricyanide oxidation of bilirubin in non-albumin-containing
To assess the effect of serum on HRP activity, I monitored the oxidation of potassium ferrocyanide (2 mmolfL) in 1.0 mL of phosphate buffer and various amounts of serum by HRP (0.11 Mmol/L) and EtOOH (1.6 mmolfL) at 37#{176}C and 428 nm (Gilford 240). The absorptivities for potassium ferrocyanide and ferricyanide at 428 nm were 90 L . mol' cm1 and 950 L . mol' cm1, respectively.
The dissociation rate constant (K_1) of the bilirubin-albumin complex was estimated from the ordinate intercept by using a modification of the equation derived by Faerch and Jacobsen (12) :
where B is the concentration of albumin-bound bilirubin (which is nearly equal to the total bilirubin concentration); V is the initial velocity of the oxidation of bilirubin by HRP and EtOOH; Kp. is the equilibrium association constant for bilirubin and albumin; K is the rate constant for the oxidation of bilirubin by HRP and EtOOH, and a is the free albumin concentration, which can be estimated from the total bilirubin concentration minus the total albumin concentration when the bilirubin/albumin molar ratio is sufficiently low that second-site bilirubin binding is negligible. Linear plots were obtained by measuring either the change in velocity with change in HRP concentration, or the change in velocity with sample dilution, changing the total bilirubin and free albumin concentrations at a constant molar ratio for bilirubin/albumin and a constant HRP concentration. would be:
Results
Determination
where K is the rate constant in equation 1 (see Methods and Table 1 ) and M is the rate constant for oxidation of bound bilirubin by HRP and EtOOH. V, and V2 (and thus AUBC, and AUBC2) would not be equal, and results similar to those in Figure 1A would be expected. If, however, the HRP concentration were also changed by a factor X at C2 (i.e., the molar ratios of bilirubin/albumin and bilirubin/HRP are both constant at each dilution), then V2 is increased by the factor X. AUBC2, however, does not change, and results similar to those seen in Figure 1A would be expected: 
But repeating the dilutional experiments in Figure 1A , keeping both the bilirubin/albumin and bilirubin/HRP molar ratios constant, did not give results similar to those in Figure   1A . Instead, the AUBC remained constant with sample dilution. Furthermore, it is apparent from the data in Figure  lB that (8, 9) . Furthermore, the dissociation rate constant for the bilirubin-albumin complex in serum would be lower than that for the complex in defatted albumin solutions, explaining the discrepancy between the two in Figure 1A . Extensions of dilution curves such as those in Figure 1A to higher total bilirubin concentrations should approach a maximum AUBC nearer to the actual unbound bilirubin concentration.
I extended the dilution curves of bilirubin-enriched sera or defatted albumin solutions to higher total bilirubin concentrations, keeping HRP concentration constant, and the curves indeed approached a maximum If the dilution curves are totally the result of limited dissociation of the biirubin-albumin complex, the AUBC should 
A dilution that decreases B, a, and HRP by the same factor should not affect the AUBC (i.e., the AUBC is the same before and after dilution). I determined the AUBC in defatted albumin solutions (409 zmoWL) containing bilirubin, before and after a 50-fold dilution. The bilirubin/HRP molar ratio was constant.
The AUBC was nearly the same before and after dilution (Table 2) , as predicted by equation 3. I performed similar experiments on bilirubin-enriched cord serum and jaundiced infant sera, except that the "beforedilution" sample is actually a two-fold dilution of the stock serum with phosphate buffer, required to adjust the pH. The "after-dilution" sample is a 50-fold dilution of the stock serum.
The results (Table 3) are quite different from the results with defatted albumin. The AUBC is 2.6-to 3.5-fold higher in the "before-dilution" sample, indicating that dilution-related factors other than the dissociation rate of the bilirubin-albumin complex affect the peroxidase test-possibly enhancement of HRP or bilirubin activity by serum, weak bilirubin binding competitors in serum, and (or) actual improvement of bilirubin binding with serum dilution.
The HRP activity was not enhanced by serum, as there was little change in the oxidation of ferrocyanide by HRP and EtOOH in the presence or absence of serum (Table 4) EtOOH as the bilirubin oxidizing agent ( Figure 3 ). I repeated the experiments summarized in Tables 2 and 3 , using ferncyanide instead of HRP and EtOOH, and found that the AUBC ratios before and after dilution were still 1.0 for defatted albumin and 2.6 ± 0.2 for cord serum. The enhanced AUBC in undiluted serum does not appear to be unique to the HRP-EtOOH oxidizing system. No bilirubin binding competitors could be demonstrated, either by a decline in the AUBC in bilirubin-enriched undiluted cord serum after dialysis (10 mL of cord serum dialyzed against four 500-mL changes of phosphate buffer over 24 h) or by an increase in the AUBC in serum diluted with serum ultrafiltrate instead of phosphate buffer. The HRP concentration is constant (0.23 zmol/L) in these experiments, and the results are given in Table 5 .
Thus, it would appear that either the oxidative activity of bilirubin is increased by serum or that dilution actually improves the binding of bilirubin by serum.
Discussion
Although the peroxidase method is a very sensitive test for analyzing bilirubin.-albumin binding, it is clear that the reaction conditions are extremely important and must be carefully controlled to obtain accurate data on concentrations of unbound bilirubin.
The data presented here indicate that serum behaves very differently from solutions of defatted albumin, and suggest that the latter may have limited usefulness as a model for serum binding.
The reason(s) for the very slow dissociation of the bilirubin-albumin complex in serum is unclear. The phenomenon previously thought to be oxidation of albumin-bound bilirubin seen in partly purified albumin solutions, which disappears with defatting (9, 13) , suggests that fatty acids may play a role 
(±3)
in hindering the dissociation of the bilirubin-albumin complex. The influence of fatty acids on bilirubin transport and uptake is still unclear (14) . The improvement of bilirubin binding with serum dilution is suggested by the data presented by Cashore et al. (15) , who noted differences in binding capacity when comparing sera analyzed by the standard peroxidase test (8) with a dialysis technique (MADDS method) in which undiluted serum is used (16) . Furthermore, Lamola et al. (17) , using a fluorometric test and undiluted whole blood, found primary bilirubin site binding constants 30 to 40 times lower than previously reported, suggesting that peroxidase-determined estimates of the equilibrium association constant for the primary bilirubin binding site in serum may be high owing to excessive HRP concentrations, corrections for non-existent oxidation of bound bilirubin, and dilutional enhancement of binding.
Further work needs to be done to determine dilution-influenced factors in serum that affect bilirubin-albumin binding. Caution should be used in interpreting peroxidase determinations of the unbound bilirubin concentration if high sample dilutions or excessively high HRP concentrations are used, because the concentration of unbound bilirubin tends to be underestimated, giving a potentially false-negative result. Minimal dilution with low (<0.11 smol/L) HRP concentrations may improve the accuracy of the unbound bilirubin concentration determination in serum. All the factors influencing serum binding of bilirubin must be evaluated, however, before the relation between specific values for "unbound bilirubin" and risk for bilirubin toxicity can be assessed.
It is also apparent that factors other than serum bilirubin binding (e.g., acidosis) are extremely important in assessing risk for bilirubin toxicity in jaundiced infants (3). These factors will also need to be further evaluated before the appropriate relationships between serum bilirubin binding and bilirubin toxicity can be determined.
